Ident. | Authors (with country if any) | Title |
---|
000042 (2015) |
Hasmet A. Hanagasi [Turquie] | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. |
000075 (2015) |
Eugenia Mamikonyan [États-Unis] ; Sharon X. Xie [États-Unis] ; Emilie Melvin [États-Unis] ; Daniel Weintraub [États-Unis] | Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study. |
000122 (2015) |
Kaviraja Udupa [Canada] ; Susan H. Fox [Canada] | Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD. |
000155 (2015) |
Christopher F. O'Brien [États-Unis] ; Roland Jimenez [États-Unis] ; Robert A. Hauser [États-Unis] ; Stewart A. Factor [États-Unis] ; Joshua Burke [États-Unis] ; Daniel Mandri [États-Unis] ; Julio C. Castro-Gayol [États-Unis] | NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study. |
000243 (2015) |
Joaquim J. Ferreira [Portugal] ; Anne Rosser [Royaume-Uni] ; David Craufurd [Royaume-Uni] ; Ferdinando Squitieri [Italie] ; Nicholas Mallard [États-Unis] ; Bernhard Landwehrmeyer [Allemagne] | Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial. |
000341 (2015) |
Ralf Reilmann [Allemagne] ; Marie-Laure Rouzade-Dominguez ; Carsten Saft ; Sigurd D. Süssmuth ; Josef Priller ; Anne Rosser ; Hugh Rickards ; Ludger Schöls ; Nicole Pezous ; Fabrizio Gasparini ; Donald Johns ; Georg Bernhard Landwehrmeyer ; Baltazar Gomez-Mancilla | A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease. |
000719 (2013) |
Yoshikuni Mizuno [Japon] ; Masahiro Nomoto ; Tomoyoshi Kondo ; Kazuko Hasegawa ; Miho Murata ; Masahiro Takeuchi ; Junji Ikeda ; Takayuki Tomida ; Nobutaka Hattori | Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial. |
000839 (2013) |
Asako Yoritaka [Japon] ; Masashi Takanashi ; Masaaki Hirayama ; Toshiki Nakahara ; Shigeo Ohta ; Nobutaka Hattori | Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial. |
000959 (2013) |
Esther Cubo [Espagne] ; Miguel González ; Harvey Singer ; E Mark Mahone ; Lawrence Scahill ; Kirsten R. Müller-Vahl ; Raul De La Fuente-Fernández ; Diana Armesto ; Katie Kompoliti | Impact of placebo assignment in clinical trials of tic disorders. |
000B26 (2013) |
| A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease. |
000C59 (2012) |
Esther Cubo [Espagne] ; Miguel González ; Inés Del Puerto ; Justo Garcia De Yébenes ; Olga Fernández Arconada ; José María Trejo Gabriel Y Galán | Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease. |
000F06 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain ; Marco Onofrj ; Anthony H V. Schapira ; Mohit Bhatt ; Valentina Lucini ; Rodolfo Giuliani ; Ravi Anand | A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients. |
000F14 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi ; Barbara Coffey ; Kirsten Mueller-Vahl ; Stephen Koval ; Glen Wunderlich | A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome. |
001025 (2012) |
Esther Cubo [Espagne] ; Miguel Gonzalez [Espagne] ; Inés Del Puerto [Espagne] ; Justo Garcia De Yebenes [Espagne] ; Olga Fernández Arconada [Espagne] ; José Maria Trejo Gabriel Y Galan [Espagne] | Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease |
001227 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
001234 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A Multicenter Randomized Placebo-Controlled Clinical Trial of Pramipexole for Tourette's Syndrome |
001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
001331 (2011) |
Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study |
001397 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
001590 (2011) |
Helge Hellriegel [Allemagne] ; Jan Raethjen [Allemagne] ; G. Deuschl [Allemagne] ; Jens Volkmann [Allemagne] | Levetiracetam in primary orthostatic tremor: A double‐blind placebo‐controlled crossover study |
001833 (2011) |
Kitty K. Wong [Australie] ; Jane E. Alty [Australie] ; Amanda G. Goy [Australie] ; Sanjay Raghav [Australie] ; David C. Reutens [Australie] ; Peter A. Kempster [Australie] | A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease |